Stocks · Health care · Pharmaceutical Preparations

Zentalis Pharmaceuticals, Inc.

ZNTL Clue Score26
United States Fiscal year ends December CIK 0001725160 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Julia Marie Eastland
9 Feb 2026
CEO & President
Sell
889
$2.39
$2.13K
Ingmar Bruns
9 Feb 2026
Chief Medical Officer
Sell
335
$2.39
$801.62
Julia Marie Eastland
6 Feb 2026
CEO & President
Sell
7,866
$2.43
$19.11K
Ingmar Bruns
6 Feb 2026
Chief Medical Officer
Sell
2,962
$2.43
$7.20K
Matrix Capital Management Company, LP
15 Dec 2025
10% owner
Sell indirect
7,500,000
$1.33
$9.98M

What was left out

Form 4 filings counted 18
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 409,427
History held since 8 Apr 2020